��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Efficacy and Safety of Natalizumab as Escalation Therapy in Relapsing-Remitting Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 157

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Norman Putzki, MD (Novartis Pharma AG)	No disclosure on file
	No disclosure on file
Nicholas Davies	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Majaz Moonis, MD, FAHA, FAAN (University of Massachusetts, Department of Neurology)	Dr. Moonis has nothing to disclose.
H. C. Diener, MD, FAAN (University Duisburg-Essen)	Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.